Physician profile
Gilbert Hernandez
NPI 1417326992
$1,925.59
in general payments reported to CMS, 2019-2025
17 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $397 · 2023: $849 · 2024: $516 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $464.64 | 2022-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $320.43 | 2022-2024 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $287.55 | 2022-2024 | Mounjaro, Jardiance |
| Otsuka America Pharmaceutical, INC. | $283.84 | 2023-2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $195.37 | 2022-2024 | |
| Abbvie INC. | $64.29 | 2022-2025 | |
| Pfizer INC. | $60.72 | 2022-2023 | |
| Novo Nordisk INC | $40.54 | 2022-2023 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $34.34 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.71 | 2023 | |
| Novartis Pharmaceuticals Corporation | $27.10 | 2022 | |
| Medtronic, INC. | $26.06 | 2023 | Kyphon Express II Kyphopak Tray |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.31 | 2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $18.81 | 2022 | |
| Daiichi Sankyo INC. | $17.99 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.48 | 2023 | Trelegy Ellipta |
| Shield Therapeutics INC | $13.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.